###begin article-title 0
Additive Effects of PDGF Receptor beta Signaling Pathways in Vascular Smooth Muscle Cell Development
###end article-title 0
###begin article-title 1
Development of Vascular Smooth Muscle Cells Depends on Signaling Synergy
###end article-title 1
###begin p 2
The platelet-derived growth factor beta receptor (PDGFRbeta) is known to activate many molecules involved in signal transduction and has been a paradigm for receptor tyrosine kinase signaling for many years. We have sought to determine the role of individual signaling components downstream of this receptor in vivo by analyzing an allelic series of tyrosine-phenylalanine mutations that prevent binding of specific signal transduction components. Here we show that the incidence of vascular smooth muscle cells/pericytes (v/p), a PDGFRbeta-dependent cell type, can be correlated to the amount of receptor expressed and the number of activated signal transduction pathways. A decrease in either receptor expression levels or disruption of multiple downstream signaling pathways lead to a significant reduction in v/p. Conversely, loss of RasGAP binding leads to an increase in this same cell population, implicating a potential role for this effector in attenuating the PDGFRbeta signal. The combined in vivo and biochemical data suggest that the summation of pathways associated with the PDGFRbeta signal transduction determines the expansion of developing v/p cells.
###end p 2
###begin p 3
Using both in vivo and biochemical approaches, the summation of pathways associated with the PDGFRbeta signal transduction is shown to determine the expansion of a specific PDGFRbeta-dependent cell type
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 301 327 301 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Valius1">Valius and Kazlauskas 1993</xref>
###xml 458 479 458 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Fambrough1">Fambrough et al. 1999</xref>
###xml 603 621 603 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Flores1">Flores et al. 2000</xref>
###xml 623 641 623 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Halfon1">Halfon et al. 2000</xref>
###xml 643 657 643 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Xu1">Xu et al. 2000</xref>
Although signal transduction by receptor tyrosine kinases (RTKs) has been studied extensively, the roles of individual signaling proteins downstream of these receptors are a matter of debate. Some studies have shown that disruption of particular pathways leads to loss of specific cellular functions (Valius and Kazlauskas 1993). Others have suggested that it is the sum of the signals that results in the unique cellular outcomes directed by each receptor (Fambrough et al. 1999). Yet others have demonstrated that the interpretation of receptor signals is determined by the distinct cellular history (Flores et al. 2000; Halfon et al. 2000; Xu et al. 2000). Because many of these conclusions have been reached in diverse cell types and through the analysis of different RTKs, it is difficult to determine whether results from one receptor system can be used to generalize the functions of RTK signaling.
###end p 5
###begin p 6
###xml 163 183 163 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Partanen1">Partanen et al. 1998</xref>
###xml 185 204 185 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Heuchel1">Heuchel et al. 1999</xref>
###xml 206 230 206 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Blume-Jensen1">Blume-Jensen et al. 2000</xref>
###xml 232 250 232 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kissel1">Kissel et al. 2000</xref>
###xml 252 273 252 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Tallquist2">Tallquist et al. 2000</xref>
###xml 275 298 275 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Klinghoffer2">Klinghoffer et al. 2001</xref>
###xml 306 323 306 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Maina1">Maina et al. 2001</xref>
###xml 435 455 435 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Partanen1">Partanen et al. 1998</xref>
###xml 457 481 457 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Blume-Jensen1">Blume-Jensen et al. 2000</xref>
###xml 483 501 483 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kissel1">Kissel et al. 2000</xref>
###xml 503 520 503 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Maina1">Maina et al. 2001</xref>
###xml 797 820 789 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Klinghoffer3">Klinghoffer et al. 2002</xref>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
Recently, several labs have dissected the roles of RTK modular signaling components by generating point mutations in cytoplasmic domains of the receptors in mice (Partanen et al. 1998; Heuchel et al. 1999; Blume-Jensen et al. 2000; Kissel et al. 2000; Tallquist et al. 2000; Klinghoffer et al. 2001, 2002; Maina et al. 2001). These studies have revealed a unique requirement for individual signaling components in specific cell types (Partanen et al. 1998; Blume-Jensen et al. 2000; Kissel et al. 2000; Maina et al. 2001). In contrast, similar experiments on platelet-derived growth factor receptor alpha (PDGFRalpha) signaling mutants have demonstrated that phosphatidylinositol 3'-kinase (PI3K) and Src family kinase (SFK) signal transduction pathways play roles in oligodendrocyte development (Klinghoffer et al. 2002). These experiments suggest that requirements for signal transduction vary not only by the receptor under consideration, but also by the cell lineage that is receiving the signal.
###end p 6
###begin p 7
###xml 441 460 432 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Claesson-Welsh1">Claesson-Welsh 1994</xref>
###xml 462 480 453 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Heldin2">Heldin et al. 1998</xref>
###xml 664 690 652 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Heldin1">Heldin and Westermark 1999</xref>
###xml 692 713 680 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Betsholtz1">Betsholtz et al. 2001</xref>
###xml 890 907 875 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kypta1">Kypta et al. 1990</xref>
###xml 916 942 901 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kazlauskas1">Kazlauskas and Cooper 1990</xref>
###xml 944 962 929 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kundra1">Kundra et al. 1994</xref>
###xml 964 986 949 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Wennstrom1">Wennstrom et al. 1994a</xref>
###xml 1001 1019 986 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Yokote1">Yokote et al. 1994</xref>
###xml 1030 1048 1015 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kaplan1">Kaplan et al. 1990</xref>
###xml 1050 1072 1035 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kazlauskas2">Kazlauskas et al. 1990</xref>
###xml 1135 1154 1120 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Vignais1">Vignais et al. 1996</xref>
###xml 1163 1184 1148 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Arvidsson1">Arvidsson et al. 1994</xref>
###xml 1193 1211 1178 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Yokote2">Yokote et al. 1996</xref>
###xml 1289 1311 1274 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kazlauskas3">Kazlauskas et al. 1993</xref>
###xml 1313 1335 1298 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Lechleider1">Lechleider et al. 1993</xref>
###xml 1371 1395 1348 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Meisenhelder1">Meisenhelder et al. 1989</xref>
###xml 1397 1417 1374 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Morrison1">Morrison et al. 1990</xref>
###xml 1429 1450 1406 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Nishimura1">Nishimura et al. 1993</xref>
The platelet-derived growth factor receptor beta (PDGFRbeta) has not only been studied physiologically, but also has been the focus of intensive biochemical analysis. Upon ligand binding, the PDGFRbeta dimerizes and is autophosphorylated on as many as 13 cytoplasmic tyrosine residues. These phosphorylated tyrosines become binding sites for SH2 domain-containing proteins that initiate a number of signal transduction pathways (reviewed by Claesson-Welsh 1994; Heldin et al. 1998). The pathways downstream of the PDGFRbeta control multiple cellular functions, including proliferation, migration, matrix deposition, and immediate early gene induction (reviewed by Heldin and Westermark 1999; Betsholtz et al. 2001). At least ten distinct SH2 domain-containing proteins can bind the phosphorylated PDGFRbeta and activate downstream signal transduction cascades. These molecules include SFK (Kypta et al. 1990), PI3K (Kazlauskas and Cooper 1990; Kundra et al. 1994; Wennstrom et al. 1994a, 1994b), Shc (Yokote et al. 1994), RasGAP (Kaplan et al. 1990; Kazlauskas et al. 1990), signal transducers and activators of transcription (STATs) (Vignais et al. 1996), Grb2 (Arvidsson et al. 1994), Grb7 (Yokote et al. 1996), SH2-containing phosphotyrosine phosphatase (SHP-2, also known as SH-PTP2) (Kazlauskas et al. 1993; Lechleider et al. 1993), phospholipase Cgamma (PLCgamma) (Meisenhelder et al. 1989; Morrison et al. 1990), and Nck (Nishimura et al. 1993). While multiple downstream effects have been attributed to activation of these pathways, their relative importance downstream of the PDGFRbeta has not been determined in vivo.
###end p 7
###begin p 8
###xml 267 285 261 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Leveen1">Lev&#233;en et al. 1994</xref>
###xml 287 299 281 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Soriano1">Soriano 1994</xref>
###xml 389 415 383 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hungerford1">Hungerford and Little 1999</xref>
###xml 563 583 554 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Lindahl1">Lindahl et al. 1997a</xref>
###xml 591 612 582 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hellstrom1">Hellstr&#246;m et al. 1999</xref>
###xml 614 630 605 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Enge1">Enge et al. 2002</xref>
###xml 773 794 761 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hellstrom1">Hellstr&#246;m et al. 1999</xref>
###xml 970 991 958 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hellstrpm1">Hellstr&#246;m et al. 2001</xref>
We have concentrated our present analyses on signal transduction by the PDGFRbeta. Previous studies using a null allele of the receptor have demonstrated that PDGFRbeta signal transduction is required for a subset of vascular smooth muscle cells and pericytes (v/p) (Leveen et al. 1994; Soriano 1994). These cells are the mesenchymal support cells that surround blood vessels (reviewed by Hungerford and Little 1999). Brain pericytes, kidney mesangial cells, retinal mural cells, and limb and skin pericytes have all been recognized as PDGFRbeta-dependent cells (Lindahl et al. 1997a, 1998; Hellstrom et al. 1999; Enge et al. 2002). Studies have indicated that the PDGFRbeta is likely to play a key role in the proliferation, migration, or both of a progenitor population (Hellstrom et al. 1999). These results explain why defective PDGF signal transduction results in a reduction of the v/p cell lineage and ultimately in perinatal lethality due to vessel instability (Hellstrom et al. 2001).
###end p 8
###begin p 9
###xml 158 177 151 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Heuchel1">Heuchel et al. 1999</xref>
###xml 179 200 172 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Tallquist2">Tallquist et al. 2000</xref>
###xml 506 514 496 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g001">Figure 1</xref>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
To examine the roles of PI3K and PLCgamma downstream of the PDGFRbeta, we have previously disrupted their binding sites in the receptor's cytoplasmic domain (Heuchel et al. 1999; Tallquist et al. 2000). Surprisingly, no overt phenotypes were detected in homozygous mutants lacking these two pathways, and deficiencies were observed only when the animals were challenged physiologically. To assess the roles of the remaining signal transduction pathways, we have created a PDGFRbeta allelic series in mice (Figure 1). We refer to this series as the F series because it contains Y-F mutations at the known phosphorylated tyrosine residues. Using v/p cell number as a readout for PDGFRbeta signal transduction, we have determined that the level of receptor expressed as well as the sum of signaling pathways induced by the PDGFRbeta determines the number of v/p cells that form. These results provide an example of RTK signal transduction quantitatively controlling cellular development.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Generation of the Allelic Series
###end title 11
###begin p 12
###xml 270 289 264 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Heuchel1">Heuchel et al. 1999</xref>
###xml 291 312 285 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Tallquist2">Tallquist et al. 2000</xref>
###xml 406 414 397 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g001">Figure 1</xref>
###xml 709 714 694 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F1/F1</sup>
###xml 778 779 757 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 904 912 883 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g002">Figure 2</xref>
###xml 1028 1029 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 1143 1151 1119 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g002">Figure 2</xref>
###xml 1245 1253 1221 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g002">Figure 2</xref>
###xml 1499 1500 1472 1473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 1799 1819 1765 1785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Escobedo1">Escobedo et al. 1988</xref>
###xml 1853 1854 1816 1817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 2294 2315 2251 2272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hiratsuka1">Hiratsuka et al. 1998</xref>
###xml 1421 1425 <span type="species:ncbi:10090">mice</span>
Previous studies of the PDGFRbeta have revealed an essential role for this receptor in v/p development, but attempts to identify essential biochemical signals thus far have demonstrated that loss of certain signaling pathways only diminishes PDGFRbeta-driven responses (Heuchel et al. 1999; Tallquist et al. 2000). To study key signaling pathways, we have generated an allelic series of PDGFRbeta mutants. Figure 1 illustrates the mutations that we have generated in the PDGFRbeta locus and the signaling pathways that are disrupted by these mutations. Each mutant will be referred to by the number of tyrosines (Y) that have been mutated. For example, the mutation in the RasGAP-binding site is the PDGFRbetaF1/F1 or F1/F1 mutant. The truncation mutation of the PDGFRbeta (betaT) was created by the introduction of a frameshift and subsequent premature stop codon downstream of the RasGAP-binding site. Figure 2 illustrates the targeting events that were used to generate the series of mutants. The F1-, F2-, F3-, F5-, and betaT-targeted mutations were generated by engineering Y-F, Y-I, or frameshift mutations in the same targeting vector (Figure 2A). The F7 mutation was generated by targeting the F5 heterozygous embryonic stem (ES) cells (Figure 2B; see Materials and Methods). Cells that contained all mutations on the same allele, as determined by Southern blotting, were used to generate the F7 line. All mutant mice were viable and fertile as homozygotes except the truncation allele, betaT, which lacks the second half of the kinase domain and the SHP-2- and PLCgamma-binding sites. Based on a similar mutation in the PDGFRbeta, we assume that this receptor is kinase deficient and incapable of inducing DNA synthesis, but it still should bind ligand and undergo receptor downregulation (Escobedo et al. 1988). Embryos homozygous for the betaT allele die perinatally with a phenotype identical to that of the PDGFRbeta null embryos. E18 embryos exhibit edema and hemorrhaging in multiple tissues, including the kidney, brain, and skin (data not shown). These results suggest that PDGFRbeta kinase activity is required for v/p development and that the receptor cannot function in the absence of kinase activity, unlike another RTK, vascular endothelial cell growth factor receptor 1 (Hiratsuka et al. 1998).
###end p 12
###begin title 13
Identification of V/P Cells
###end title 13
###begin p 14
###xml 204 210 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XlacZ4</italic>
###xml 264 270 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XlacZ4</italic>
###xml 423 441 420 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Tidhar1">Tidhar et al. 2001</xref>
###xml 613 614 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g007">7</xref>
###xml 616 617 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g008">8</xref>
###xml 623 624 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g009">9</xref>
###xml 782 802 776 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Lindahl1">Lindahl et al. 1997a</xref>
###xml 804 825 798 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hellstrom1">Hellstr&#246;m et al. 1999</xref>
###xml 827 843 821 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Enge1">Enge et al. 2002</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 282 287 <span type="species:ncbi:10090">mouse</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
###xml 1529 1533 <span type="species:ncbi:10090">mice</span>
We examined the blood vessels of F series homozygous mice by histology and detected no gross abnormalities (data not shown). To obtain a more global perspective of v/p cell populations, we introduced the XlacZ4 transgenic marker into our F series mutant mice. The XlacZ4 transgenic mouse expresses nuclear beta-galactosidase in certain populations of differentiated, nonproliferating v/p cells in the embryo and the adult (Tidhar et al. 2001). As described below, using this marker in adult animals, we identified vascular defects in the F5 and F7 mice in the tissues of the eyes, hearts, and brains (see Figures 7, 8, and 9; data not shown). This observation suggests that both the F5 and F7 alleles function suboptimally in tissues known to require PDGFRbeta signal transduction (Lindahl et al. 1997a; Hellstrom et al. 1999; Enge et al. 2002). Although both of these mutations cause notable phenotypes in some v/p populations, we have not observed pathologies in all populations of PDGFRbeta-dependent v/p cells. V/p cell populations with no overt phenotype in the F5 and F7 mice include the kidney mesangial cells and pericytes in the skin and skeletal muscle (data not shown). We have observed a modest decrease in the number of nuclei present in F5/F5 and F5/- kidney glomeruli, but have not detected glomerulosclerosis with Masson trichrome stain (data not shown). The lack of any pathological phenotype in these tissues suggests either that the reduction in v/p cells is less severe than in the case of the PDGFRbeta null mice, that the PDGFRalpha may be coexpressed in these same tissues, or that these tissues can function adequately even with reduced v/p cell numbers.
###end p 14
###begin p 15
###xml 284 306 273 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Schatteman1">Schatteman et al. 1992</xref>
###xml 308 328 297 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Lindahl2">Lindahl et al. 1997b</xref>
###xml 330 350 319 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Takakura1">Takakura et al. 1997</xref>
###xml 352 369 341 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Zhang1">Zhang et al. 1998</xref>
###xml 371 391 360 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Karlsson1">Karlsson et al. 2000</xref>
###xml 555 558 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</sup>
###xml 688 708 665 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hamilton1">Hamilton et al. 2003</xref>
###xml 834 842 811 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g003">Figure 3</xref>
###xml 978 984 947 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XlacZ4</italic>
###xml 1327 1328 1288 1289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1377 1385 1338 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g003">Figure 3</xref>
###xml 1541 1560 1498 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Seifert1">Seifert et al. 1998</xref>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 1681 1685 <span type="species:ncbi:10090">mice</span>
Because some populations of v/p cells appear to be more dependent on PDGFRbeta signal transduction than others, we reasoned that the PDGFRalpha might be coexpressed in the less-affected v/p populations. Although PDGFRalpha has been reported in a variety of mesenchymal cell lineages (Schatteman et al. 1992; Lindahl et al. 1997b; Takakura et al. 1997; Zhang et al. 1998; Karlsson et al. 2000), we wanted to determine whether any v/p populations express the PDGFRalpha or whether it may be upregulated in any of the F series mice. We crossed the PDGFRalphaGFP line of mouse, which expresses a nuclear-localized green fluorescent protein (GFP) under the control of the PDGFRalpha promoter (Hamilton et al. 2003), with the F5 mutant mice and compared the GFP expression pattern to the pattern of v/p cells in the kidney, eye, and brain (Figure 3; data not shown). We have used three independent markers to designate v/p cells: smooth muscle actin alpha (alphaSMA), desmin, and the XlacZ4 transgene. Although PDGFRalpha-expressing cells are found in the same tissues as v/p cell markers, there is no overlapping expression of GFP with any of the v/p cell markers in the arteries or veins in the vessels of the eye and brain. PDGFRalpha-expressing cells are also absent from the larger vessels of the kidney, but a population of GFP+ cells is detected within the kidney glomerulus (Figure 3A). These may be either kidney mesangial cells or vascular adventitial fibroblasts. Both are populations of cells that are known to express the PDGFRalpha (Seifert et al. 1998). These data indicate that PDGFRalpha is not expressed or upregulated in two of the most affected tissues of the mutant mice, the eye and the brain, but could be functioning as a surrogate coreceptor with the PDGFRbeta.
###end p 15
###begin title 16
V/P Development
###end title 16
###begin p 17
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XlacZ4</italic>
###xml 450 458 450 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g004">Figure 4</xref>
###xml 675 681 675 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XlacZ4</italic>
###xml 175 180 <span type="species:ncbi:10090">mouse</span>
To determine whether the reduction in v/p was caused by a gradual loss or a developmental defect, we examined pericyte populations in wild-type and mutant embryos. The XlacZ4 mouse marker can be used to identify specific v/p cell populations as early as E12.5. We chose to observe pericytes at E14.5 because at this timepoint v/p are abundant in wild-type animals in several tissues, including the developing spinal cord and intercostal vasculature. Figure 4 demonstrates whole-mount visualization of the v/p cell populations in E14.5 wild-type embryos and the most severe F series mutant embryo (F7/-). After examining several litters of F series mutant embryos bearing the XlacZ4 marker, it was clear that the entire panel of F series homozygous mutant embryos could be distinguished from wild-type embryos simply by the degree that blood vessels had acquired v/p (data not shown).
###end p 17
###begin p 18
###xml 233 251 230 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Leveen1">Lev&#233;en et al. 1994</xref>
###xml 559 567 556 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g005">Figure 5</xref>
###xml 696 697 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g005">5</xref>
###xml 702 703 696 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g006">6</xref>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
To obtain a quantitative view of these results, we chose to focus on the spinal cord pericyte population. These cells begin to form at E10.5 in a rostral-to-caudal fashion in the embryo and require PDGFRbeta signals for development (Leveen et al. 1994). Cross-sections through the developing spinal cord (neural tube) provide a relatively uniform area for quantitation. We can consistently identify a particular maturation stage of the developing vasculature based on its axial level within the embryo, and the pericytes can often be found as isolated cells (Figure 5). Using the entire panel of PDGFRbeta mutant mice, we compared pericyte numbers between the different F series mutants (Figures 5 and 6). In all mutants examined, with the exception of the F1 mutation, we observed a decreased incidence of pericytes when compared to the wild-type embryos. The reduction in pericyte numbers ranged from 42% to 77%. This reduction was present at the more mature axial level of the heart as well as at the axial level of the kidney.
###end p 18
###begin p 19
The F7/F7 mutant embryos are the only embryos that exhibited a difference between the number of pericytes at the heart level versus the number at the level of the kidney. All other mutants demonstrated similar numbers at both levels, indicating that pericyte development is disrupted and does not reach homeostasis as the tissue matures. Because the F7 is the most severely affected allele, it is possible that the difference between the heart and kidney levels is due to a developmental delay in v/p formation. Pericyte development may still be proceeding at the level of the kidney in these embryos. At the more mature level of the heart, the F7/F7 pericyte populations have reached a steady-state level and resemble v/p numbers more similar to those observed in the F5/F5 embryos.
###end p 19
###begin p 20
###xml 231 249 228 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Crosby1">Crosby et al. 1998</xref>
###xml 414 415 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g005">5</xref>
###xml 421 422 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g006">6</xref>
###xml 598 601 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 683 695 671 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Soriano1">Soriano 1994</xref>
Previously, chimeric analysis had demonstrated that PDGFRbeta heterozygous cells do not contribute extensively to the smooth muscle cell compartment, suggesting that heterozygous cells may have reduced v/p developmental potential (Crosby et al. 1998). To find out whether receptor levels had any impact on v/p cells in our system, we crossed animals bearing the PDGFRbeta null allele to our mutant series (Figures 5B and 6B). We observed an even further reduction in pericyte levels, resulting in a 70%-92% decrease in pericytes when compared to wild-type embryos. Interestingly, even the PDGFRbeta+/- embryos, which exhibit a approximately 50% reduction in PDGFRbeta messenger RNA (Soriano 1994), demonstrate a nearly 40% decrease in pericytes. This result suggests that the quantity of receptor impacts the number of pericytes. Another observation from this data is that even the F7/- embryos can induce cell development at levels greater than the null. In fact, the F7/- animals survive, whereas the PDGFRbeta nulls do not. This is a rather surprising result given that most of the downstream signal transduction molecules that directly interact with the receptor have been dissociated.
###end p 20
###begin p 21
###xml 250 258 247 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g006">Figure 6</xref>
While most of the F series alleles demonstrate a decrease in v/p cells, the F1 allele results in an apparent increase in spinal cord pericytes. Although the increase is most pronounced when we compare the F1 hemizygote to the PDGFRbeta heterozygote (Figure 6), an increase is also observed when comparing F1/F1 embryos and wild-type embryos. In fact, the level of pericytes in the F1/- embryos is very similar to those in the wild-type. These data demonstrate two interesting findings. One is that RasGAP may play a role in PDGFRbeta signal attenuation and that loss of this pathway results in increased PDGFRbeta signals. The second is that v/p numbers may not be tightly controlled and that PDGFRbeta signaling can result in more cells.
###end p 21
###begin p 22
###xml 252 272 249 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Benjamin1">Benjamin et al. 1998</xref>
###xml 274 297 271 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Klinghoffer2">Klinghoffer et al. 2001</xref>
###xml 299 315 296 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Enge1">Enge et al. 2002</xref>
###xml 517 525 514 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g007">Figure 7</xref>
###xml 596 619 590 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Klinghoffer2">Klinghoffer et al. 2001</xref>
###xml 621 637 615 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Enge1">Enge et al. 2002</xref>
###xml 828 836 822 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g007">Figure 7</xref>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
To determine whether the signaling pathways affected other v/p populations in the same manner, we have examined the v/p population in the retina. It has been shown previously that PDGFB and PDGFRbeta signaling controls pericyte development in the eye (Benjamin et al. 1998; Klinghoffer et al. 2001; Enge et al. 2002). Adult mice transheterozygous for one null allele and one F5 or F7 allele exhibited severe eye defects. These defects were first observed as an opacity and sometimes as visible hemorrhage in the eye (Figure 7A), as previously described for PDGFRbeta and PDGFB signaling mutants (Klinghoffer et al. 2001; Enge et al. 2002). The F5 and F7 hemizygous mutant mice possessed fewer discontinuous blood vessels and overgrowth of retinal cells. This phenotype occurred with 100% penetrance, but with variable severity (Figure 7C), and was detectable sometimes as early as 4 d after birth. The presence of a pathological condition suggests that the F5 and F7 alleles have compromised receptor function when compared to the wild-type, F1, F2, and F3 alleles and demonstrates that retinal pericytes are also dependent on the PDGFRbeta signaling pathways that we have disrupted.
###end p 22
###begin p 23
###xml 88 94 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XlacZ4</italic>
###xml 233 241 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g008">Figure 8</xref>
###xml 508 511 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
To examine the retinal pericytes in the entire F series, we again used mice bearing the XlacZ4 transgene. At 4 wk of age the retinal vasculature is mature and can be isolated from the lens and pigmented epithelium for visualization. Figure 8 illustrates that homozygotes for the F1, F2, and F3 mutant alleles are indistinguishable from wild-type eyes; however, F5/F5 and F7/F7 eyes exhibit reduced numbers of pericytes. Even without the ability to quantitate these differences, it is clear that the PDGFRbeta+/-, F5/F5, F7/F7, F5/-, and F7/- mutant retinas have a reduction in v/p when compared to wild-type eyes, reinforcing the requirement for multiple PDGFRbeta signal transduction pathways in v/p development.
###end p 23
###begin p 24
###xml 369 377 369 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g009">Figure 9</xref>
###xml 674 682 674 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g009">Figure 9</xref>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
A final tissue where we have examined v/p formation is the heart. F2 and F3 homozygotes and transheterozygotes were indistinguishable from wild-type and heterozygous hearts, respectively. Consistent with our observations in the eye and the nervous system, the F5 and F7 mutant alleles display abnormalities in the vascular coating of their coronary arteries and veins (Figure 9; data not shown). F5/- and F7/- mice often exhibited a variety of heart abnormalities, including enlarged ventricles, increased heart:body mass ratio, dilated atria, and fibrosis (data not shown). In contrast, the F1/+ mice appeared to have more extensive v/p coating on their coronary arteries (Figure 9). In agreement with the data from the nervous system and the eye, the F5 and F7 mutant alleles have a significant reduction in v/p cells.
###end p 24
###begin p 25
Taken together, these results demonstrate several important findings for PDGFRbeta signal transduction. First, the number of pericytes formed directly correlates with the number of signaling pathways transducing PDGFRbeta activity. Second, a reduction in pericytes is observed even when only the amount of receptor is affected. Finally, although SH2 domain-containing proteins impact v/p numbers, the intrinsic kinase activity of the receptor may play a role in transmitting the PDGFRbeta signal because the truncation mutation does not exhibit any rescue of v/p development, while the F7 mutant allele that transmits primarily through kinase activity (owing to loss of the SH2 domain-containing protein-binding sites) still supports v/p development sufficient for viability.
###end p 25
###begin title 26
Downstream Signal Transduction
###end title 26
###begin p 27
###xml 84 110 84 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Valius1">Valius and Kazlauskas 1993</xref>
###xml 112 131 112 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Heuchel1">Heuchel et al. 1999</xref>
###xml 133 154 133 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Tallquist2">Tallquist et al. 2000</xref>
###xml 493 502 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g010">Figure 10</xref>
###xml 808 817 793 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g010">Figure 10</xref>
###xml 1100 1109 1078 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g010">Figure 10</xref>
###xml 1115 1117 1093 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g010">10</xref>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
Because F2, F3, and F5 mutant receptors have been previously studied biochemically (Valius and Kazlauskas 1993; Heuchel et al. 1999; Tallquist et al. 2000), we have focused our biochemical analysis on the F1 and F7 mutant receptors' signal transduction to verify the effects of these particular mutations on downstream signal transduction cascades. We have used mouse embryo fibroblasts (MEFs) for these analyses. All lines of MEFs that we generated expressed the PDGFRbeta at similar levels (Figure 10D) as well as the PDGFRalpha (data not shown). To avoid stimulation of the PDGFRalpha by PDGFBB, we downregulated PDGFRalpha surface expression by pretreatment with PDGFAA 2 h before PDGFBB stimulation. In all cell lines examined, we observed an increase in tyrosine phosphorylation in response to ligand (Figure 10A). The most evident phosphorylated bands are around 200 kd, which are likely to be the PDGFRalpha and PDGFRbeta. Although we have mutated seven of the 13 tyrosines, a significant amount of phosphorylation is observed in all cell lines, albeit at lower levels in the F7/- cell line (Figure 10A and 10B). In the whole-cell lysate phosphotyrosine blot, the phosphorylated protein detected at 200 kd is likely cytoplasmic PDGFRalpha, as it is reduced in F7 cells after downregulation of the PDGFRalpha.
###end p 27
###begin p 28
###xml 143 152 143 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g010">Figure 10</xref>
###xml 323 342 323 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Johnson1">Johnson et al. 1996</xref>
###xml 614 630 611 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Mori1">Mori et al. 1993</xref>
###xml 632 651 629 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Twamley1">Twamley et al. 1993</xref>
###xml 653 677 650 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Vaillancourt1">Vaillancourt et al. 1995</xref>
###xml 679 697 676 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Fanger1">Fanger et al. 1997</xref>
Because we have disrupted only one of the potential Src-binding sites, we examined the level of Src activation downstream of our F7 cell line (Figure 10B). Upon PDGFBB addition, there was an increase in the amount of Src phosphorylated on tyrosine 418 (a site whose phosphorylation is required for full catalytic activity; Johnson et al. 1996). In contrast, in the F7/F7 MEFs, we did not observe any increase in Src activation. These results are in agreement with other reports that demonstrate that a mutation at amino acid 578 of the PDGFRbeta is sufficient for reducing the level of Src binding and activation (Mori et al. 1993; Twamley et al. 1993; Vaillancourt et al. 1995; Fanger et al. 1997).
###end p 28
###begin p 29
###xml 138 156 135 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Franke1">Franke et al. 1995</xref>
###xml 417 426 414 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g010">Figure 10</xref>
Two potential downstream targets of PDGFRbeta activation are activation of extracellular signal-related kinases 1 and 2 (ERK1/2) and AKT (Franke et al. 1995). As expected, phosphorylation of ERK1/2 and AKT is reduced or absent in the F7 homozygous and hemizygous mutant cell lines, but cells expressing at least one copy of the wild-type receptor are capable of inducing the activation of these downstream molecules (Figure 10C). These data demonstrate that loss of seven tyrosine residues on the PDGFRbeta results in a severe loss of downstream signal transduction. In contrast, cells bearing even just one copy of the F1 receptor show increased phosphorylation of ERK1/2. These data are in concordance with the in vivo data, which show that lack of the RasGAP-binding site on the receptor results in an increase in the downstream signaling events and a subsequent increase in v/p. Therefore, the F1 mutant receptor has increased activity while the F7 receptors have decreased activation of these same pathways, despite having apparently normal levels of kinase activity.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 615 641 612 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Heemskerk1">Heemskerk and DiNardo 1994</xref>
###xml 643 661 640 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Nellen1">Nellen et al. 1996</xref>
###xml 663 680 660 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Zecca1">Zecca et al. 1996</xref>
###xml 682 708 679 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Ferrell1">Ferrell and Machleder 1998</xref>
###xml 710 726 707 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Gong1">Gong et al. 2001</xref>
RTK signal transduction plays an important role in directing many cellular activities. We have used an in vivo system to analyze how cellular development relates to the signaling pathways downstream of the PDGFRbeta. Examination of the v/p population demonstrates a quantitative relationship between the extent that signals are being transduced and the number of v/p that form. Several other studies have demonstrated that combinations of signal transduction pathways may dictate cellular outcomes. Examples of these are T cell development in the immune system and gradients of morphogens in developmental systems (Heemskerk and DiNardo 1994; Nellen et al. 1996; Zecca et al. 1996; Ferrell and Machleder 1998; Gong et al. 2001).
###end p 31
###begin p 32
###xml 173 176 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
In our system, the signal can be affected in two ways. The first is by the amount of receptor expressed at the cell surface. V/p numbers are significantly lower in PDGFRbeta+/- embryos when compared to wild-type controls. In this situation there is a decrease in overall signal, but no specific, directly associated pathway is disrupted. This demonstrates a quantitative role for receptor activity. The second influence on PDGFRbeta signal transmission is by the number of associated SH2 domain-containing proteins. Loss of even a single pathway results in reduction of v/p, and as the number of disrupted pathways increases, there is a concomitant decrease in v/p. There is no significant difference between the F2 and the F3 mutant alleles, but there is a noticeable difference when the number of mutations is further increased. These signaling differences as illustrated by v/p number and the presence of vascular pathologies can be categorized in the mutant alleles by the following hierarchy: F1 > wild-type > F2 = F3 > F5 > F7 > null. In addition, hemizygotes show an even further reduction in v/p when compared to the F series homozygotes. This suggests that specific effector pathways may play more of a role in fine-tuning PDGFRbeta signals.
###end p 32
###begin p 33
###xml 736 759 723 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Klinghoffer2">Klinghoffer et al. 2001</xref>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
In total, our results demonstrate that PDGFRbeta signal transduction is regulated not only by direct binding of signal transduction molecules, but also by receptor expression levels, possibly reflecting inherent kinase activity. In addition, no particular signaling pathway that we have analyzed is absolutely required for transmission of PDGFRbeta signals, because even the F7 allele has a phenotype less severe than the null. In support of the observation that receptor levels and kinase activity may have a direct role in signal transduction, we have observed that a chimeric PDGFR that has the extracellular domain of the PDGFRbeta but the intracellular domain of the PDGFRalpha exhibits a more severe phenotype than the F5 allele (Klinghoffer et al. 2001). This chimeric receptor can signal through all of the same downstream components as the PDGFRbeta except for RasGAP, suggesting that the more severe vascular defects in these chimeric receptor mice may be due to reduced kinase activity and/or expression levels of the chimeric receptor.
###end p 33
###begin p 34
###xml 645 676 635 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Klinghoffer1">Klinghoffer and Kazlauskas 1995</xref>
###xml 678 695 668 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Ekman1">Ekman et al. 1999</xref>
The PDGFRbeta's signaling pathways appears to dictate the absolute numbers of v/p that form, but how the individual pathways contribute to this phenotype remains to be tested. In fact, very little difference in numbers of v/p is observed between the F2 and the F3 mutants, suggesting that PLCgamma signals may be somehow redundant with or dependent on the PI3K pathway. In contrast, loss of additional pathways leads to an incremental loss of v/p. The difference between the F3 and the F5 mutations is the ability to bind SHP-2 and RasGAP, and it has been proposed that both of these molecules play roles in downregulating the PDGFRbeta signal (Klinghoffer and Kazlauskas 1995; Ekman et al. 1999). Our results demonstrate that loss of these signaling pathways is detrimental to PDGFRbeta signal transduction and that both may have positive and negative influences on receptor activity.
###end p 34
###begin p 35
###xml 251 268 251 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Roche1">Roche et al. 1995</xref>
###xml 270 288 270 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hansen1">Hansen et al. 1996</xref>
###xml 352 370 352 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kundra1">Kundra et al. 1994</xref>
###xml 372 394 372 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Wennstrom2">Wennstrom et al. 1994b</xref>
###xml 801 822 801 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Fambrough1">Fambrough et al. 1999</xref>
There are several potential ways that loss of these signaling pathways leads to v/p reduction. One mechanism would be that each pathway contributes to a specific cellular outcome. For example, SFK's predominant role could be to promote proliferation (Roche et al. 1995; Hansen et al. 1996), whereas PI3K activity could be more important for migration (Kundra et al. 1994; Wennstrom et al. 1994b). Therefore, the combined loss of these pathways results in a net reduction in v/p, albeit for entirely different cellular reasons. A second scenario would be that all pathways lead to a single or few specific cellular conclusions. Thus, loss of any one pathway only reduces the outcome but does not ablate it. Evidence from immediate-early gene expression analysis suggests that this mechanism may occur (Fambrough et al. 1999), although this possibility does not require that all pathways contribute equally. Last, some pathways may play a primary role downstream of the receptor, while others may be more secondary.
###end p 35
###begin p 36
###xml 362 385 358 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Klinghoffer3">Klinghoffer et al. 2002</xref>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 405 410 <span type="species:ncbi:10090">mouse</span>
Our data suggest that PI3K may be a principal pathway, while the other pathways may be less significant. The F2/F2 mutant mice have a significant reduction in v/p numbers when compared to the wild-type and the heterozygous mice, and additional mutations have less of an effect than PI3K on v/p numbers. A similar situation has been observed with the PDGFRalpha (Klinghoffer et al. 2002): the phenotype of mouse embryos with loss of the PDGFRalpha-PI3K pathway was just as severe as that of embryos expressing a PDGFRalpha F7 allele (which is similar to the F7 allele of the PDGFRbeta). The pathological difference observed between the F5 and F7 alleles versus all of the other mutations suggests that SHP-2, SFK, Grb2, and RasGAP also impact pericyte development. Assessing the importance of these pathways would require generating additional alleles with different combinations of mutant sites. The only signaling differences between the F3 mutation and the F5 mutation are the SHP-2 and RasGAP pathways. This suggests that one or both of these pathways promote PDGFRbeta signaling, in contrast to the F1 mutation, which demonstrates that absence of RasGAP leads to a potential increase of PDGFRbeta signaling. This apparent contradiction may indicate that RasGAP plays both a positive and a negative role in signal transduction or that SHP-2 may have mainly a positive role in modulating this response.
###end p 36
###begin p 37
###xml 548 564 548 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Mori1">Mori et al. 1993</xref>
###xml 566 585 566 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Twamley1">Twamley et al. 1993</xref>
###xml 587 611 587 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Vaillancourt1">Vaillancourt et al. 1995</xref>
###xml 613 631 613 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Fanger1">Fanger et al. 1997</xref>
###xml 916 934 916 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Heldin2">Heldin et al. 1998</xref>
###xml 1127 1128 1124 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 1667 1687 1652 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Miyamoto1">Miyamoto et al. 1996</xref>
###xml 1689 1710 1674 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Schneller1">Schneller et al. 1997</xref>
###xml 1712 1731 1697 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Woodard1">Woodard et al. 1998</xref>
###xml 1733 1752 1718 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Boucher1">Boucher et al. 2002</xref>
###xml 1754 1775 1739 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Loukinova1">Loukinova et al. 2002</xref>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
Although we find that overall loss of downstream pathways attenuates receptor actions as demonstrated by v/p formation, it is surprising that the F7/F7 mice do not phenocopy the null animals. The F7 allele possesses disruptions at seven of the 13 known phosphorylated tyrosine residues. These mutations should disrupt a majority of the signal relay molecules downstream of the receptor. The remaining tyrosines are capable of binding SFKs, STATs, and Grbs. Based on several previous reports, disruption of Y578 affects the majority of SFK binding (Mori et al. 1993; Twamley et al. 1993; Vaillancourt et al. 1995; Fanger et al. 1997), and we have shown that SFKs do not become activated after stimulation of the F7 receptor. As for the signaling roles of STAT and Grb2 downstream of the receptor, little direct function has been demonstrated for these remaining effector molecules in PDGF-induced cellular responses (Heldin et al. 1998). Therefore, F7 signal transmission must use some other means than direct binding by SH2 domain-containing proteins. The receptor should still have full kinase activity, unlike the lethal betaT mutation, which is lacking half of the kinase domain and the SHP-2- and PLCgamma-binding sites. Possibly, the receptor is phosphorylating molecules that are only transiently associated. Another possibility is that other receptors may function as surrogates. The most likely surrogate is the PDGFRalpha, but we have demonstrated that in several of the v/p cell populations the PDGFRalpha is not expressed. Other candidate molecules for such a mechanism are integrins, ephrins, and the low-density lipoprotein receptor-related protein LRP (Miyamoto et al. 1996; Schneller et al. 1997; Woodard et al. 1998; Boucher et al. 2002; Loukinova et al. 2002). Although these proteins are known to cross-talk with the PDGFRbeta, it is unclear whether they have the capability to substitute for the PDGFRbeta's own signaling components.
###end p 37
###begin p 38
###xml 415 433 409 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Kundra1">Kundra et al. 1994</xref>
###xml 435 452 429 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Ekman1">Ekman et al. 1999</xref>
###xml 598 619 589 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Fambrough1">Fambrough et al. 1999</xref>
The F1 mutant allele is an interesting corollary to the F mutant series. While all of the other mutations appear to have a detrimental effect on PDGFRbeta signal transduction, the F1 mutation results in an apparent increase in PDGFRbeta activity as determined by v/p incidence. These data are in agreement with previous observations that RasGAP function decreases the Ras/MAP kinase pathway activity and migration (Kundra et al. 1994; Ekman et al. 1999). In addition, an add-back mutation of the RasGAP-binding site induced a different gene profile from the PDGFRbeta immediate-early gene profile (Fambrough et al. 1999). This suggests that RasGAP may have different signaling capabilities from the other PDGFRbeta signal transduction components.
###end p 38
###begin p 39
###xml 422 442 416 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Lindahl1">Lindahl et al. 1997a</xref>
###xml 444 465 438 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hellstrom1">Hellstr&#246;m et al. 1999</xref>
###xml 607 626 598 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Lindahl3">Lindahl et al. 1998</xref>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
The mutant mice not only uncover the role of RTK signal transduction in vivo, but they also reveal some interesting information regarding v/p cell development. For example, although v/p cell development is impaired when PDGFRbeta signal transduction is disrupted, a basal level of cells forms, in agreement with previous observations that propagation, not initiation, of v/p cell development is directed by the PDGFRbeta (Lindahl et al. 1997a; Hellstrom et al. 1999). Even in the null embryos, v/p cells can be found. It has been proposed that PDGFRbeta signals are required for the expansion of v/p cells (Lindahl et al. 1998). While this may be the case, it is curious that in the F5 and F7 animals, the pericyte numbers never reach wild-type levels, resulting in vascular pathologies.
###end p 39
###begin p 40
###xml 756 776 756 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Benjamin1">Benjamin et al. 1998</xref>
###xml 880 901 880 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Abramsson1">Abramsson et al. 2002</xref>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
There are two explanations for the observation that v/p cells never reach wild-type levels. The first is that there is constant turnover in the v/p population and that the rate of replacement in the mutant mice is below the rate of loss, resulting in a net reduction in the v/p population. Evidence against this mechanism is the failure to observe any significant proliferation in the adult wild-type animals under normal conditions or significant apoptosis in the mutant panel of mice (data not shown). The second possibility is that there is a specific window during development when v/p cells can expand. After a specified time, v/p cell number expansion could be limited, perhaps related to the ability of endothelial cells to secrete the PDGF ligand (Benjamin et al. 1998). Support for this model is the inability of nascent endothelial tubes to recruit v/p cells in tumors (Abramsson et al. 2002). The inability to develop sufficient numbers of v/p cells also appears to be recapitulated in the eye vasculature, suggesting that the maturation of the vessel is more dependent on the local environment than on the chronological age of the embryo.
###end p 40
###begin p 41
Our findings demonstrate that the combination of signaling pathways downstream of PDGFRbeta determines the total number of v/p cells. These can be modulated not only by the amount of receptor expressed at the cell surface, but also by the number of specific downstream signaling pathways activated by the receptor. Whether these results are unique to PDGFRbeta signal transduction in v/p cells or whether they can be extrapolated to other RTK remains to be demonstrated.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 43
###begin p 44
###xml 365 384 365 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Heuchel1">Heuchel et al. 1999</xref>
###xml 386 407 386 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Tallquist2">Tallquist et al. 2000</xref>
###xml 455 456 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 1571 1574 1568 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</sup>
###xml 1576 1602 1573 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Tallquist1">Tallquist and Soriano 2000</xref>
###xml 1614 1619 1611 1616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FlpeR</sup>
###xml 1621 1639 1618 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Farley1">Farley et al. 2000</xref>
###xml 309 314 <span type="species:ncbi:10090">Mouse</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 1558 1562 <span type="species:ncbi:10090">mice</span>
Point mutations that disrupt the designated signal transduction pathways were generated by changing the tyrosine residue to phenylalanine. The exception was Y1020, which was mutated to encode an isoleucine, thus generating a unique restriction site that facilitated identification of homologous recombinants. Mouse mutants F2 and F3 have been previously described (Heuchel et al. 1999; Tallquist et al. 2000). The targeting vector for the F1, F5, and betaT mutations utilized the same arms of homology as the F3 vector. The exons containing the point mutations were introduced in the arms of homology of the targeting vector by site-directed mutagenesis and verified by sequence data of PCR-amplified genomic DNA from homozygous mutant mice. The F7 mutation was generated by creating a targeting vector that incorporated the 5' arm of the F5 targeting vector with 5' genomic sequences that included the exons containing the Src- and Grb2-binding sites. Tyrosines 578 and 715 were mutated to phenylalanine to disrupt Src and Grb2 binding, respectively. This targeting vector was transfected into F5 heterozygous ES cells and screened for homologous recombination. The truncation mutation possesses a frameshift at amino acid 780, resulting in a premature stop codon after amino acid 801, 11 amino acids downstream of the RasGAP-binding site. ES cell colonies were screened initially by PCR, and positive clones were further verified by Southern blot analysis for the correct recombination at the 5' and 3' arms. The PGK-neo cassettes were removed by crossing mice to Meox2Cre (Tallquist and Soriano 2000) and ROSA26FlpeR (Farley et al. 2000) deleters.
###end p 44
###begin p 45
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XlacZ4</italic>
###xml 139 157 139 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Tidhar1">Tidhar et al. 2001</xref>
###xml 284 287 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</sup>
###xml 294 314 290 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Hamilton1">Hamilton et al. 2003</xref>
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
The majority of analyses have been carried out on a mixed 129S4 x C57BL/6 background, except where indicated. The XlacZ4 transgenic mouse (Tidhar et al. 2001) was kindly provided by Moshe Shani and crossed into the F series. We also crossed the F5 and wild-type mice to the PDGFRalphaGFP line (Hamilton et al. 2003).
###end p 45
###begin title 46
Histology, Immunohistochemistry, and Pericyte Quantitation
###end title 46
###begin p 47
Embryos and tissues were processed and embedded for sectioning according to standard protocol. We have not examined the vasculature of all PDGFRbeta-dependent tissues in the F series mutant animals. Those tissues not examined are lung, brown adipose tissue, and the adrenal gland.
###end p 47
###begin title 48
Immunohistochemistry
###end title 48
###begin p 49
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
Kidneys were removed and fixed for 20 min in 4% paraformaldehyde, 200 mum sections were then obtained by vibratome sectioning, and immunofluorescence was performed. For eye immunohistochemistry, the pigmented epithelium was removed from the mouse retinas and fixed for 10 min in 4% paraformaldehyde. Retinas and kidney slices were then blocked and subjected to immunohistochemistry for the indicated v/p marker. Antibodies were beta-galactosidase (55976; Cappel, Costa Mesa, California, United States), alphaSMA (1A4; Sigma, St. Louis, Missouri, United States), and desmin (D33; Dako Cytomation, Glostrup, Denmark). Photographs were obtained on a Zeiss Axiophot microscope (Carl Zeiss MicroImaging, Thornwood, New York, United States).
###end p 49
###begin title 50
Pericyte quantitation
###end title 50
###begin p 51
###xml 601 609 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000052-g006">Figure 6</xref>
E14.5 embryos were divided into quarters at the following levels: head-neck, neck-liver, liver-kidney, and kidney-tail. Quarters were rinsed with PBS and fixed for 20 min in 2% formaldehyde, 0.2% glutaraldehyde. They were then washed three times in PBS, stained overnight with X-Gal, transferred to PBS, photographed, post-fixed in 10% formalin, and then processed and embedded. Sections (7 mum) were generated and X-Gal-positive nuclei quantitated in the neural tube at the level of the heart and the kidney. Seven to ten samples were counted for each level; the mean of these data is represented in Figure 6. Pericytes surrounding the exterior of the neural tube were excluded from the sample. Positive nuclei were counted at 20x magnification and photographed at 10x magnification on Zeiss Axiophot microscopes. Retinas were prepared in a similar manner. The pigmented epithelium was removed prior to the initial fixation step, and the lens was not removed until after the final fixation to maintain retina shape. Images were obtained on a Nikon SMZ1000 with a Coolpix 900 camera (Nikon Corporation, Tokyo, Japan).
###end p 51
###begin title 52
Immunoprecipitation and Western Blotting
###end title 52
###begin p 53
MEFs were generated from E9-d-old or E14.5-d-old embryos. Embryos were isolated, decapitated, and eviscerated. The remaining tissue was then treated with trypsin and plated. Cells were frozen down at passages 2 and 3. Most experiments were completed on cells at passages 3-6, except for the wild-type line, which was spontaneously immortalized.
###end p 53
###begin p 54
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Cells were plated at 1 x 105 to 3 x 105 cells per well and starved for 48 h. Receptor downregulation was achieved by treating starved cells for 2 h with 100 ng/ml PDGFAA (R&D). Cells were then stimulated with PDGFBB (R&D) for 5 min and lysed.
###end p 54
###begin p 55
###xml 80 101 80 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Tallquist2">Tallquist et al. 2000</xref>
Immunoprecipitation and Western blotting were executed as previously described (Tallquist et al. 2000). Antibodies were obtained from the following sources: PDGFRbeta (06-498; Upstate Biotechnology, Lake Placid, New York, United States); PDGFRalpha (sc-338; Santa Cruz Biotechnology, Santa Cruz, California, United States); Akt (9272; Cell Signaling Technology, Beverly, Massachusetts, United States); Phospho-AKT (9271; Cell Signaling Technology); RasGAP (05-178; Upstate Biotechnology); Grb2 (610111; BD Transduction Laboratories, San Jose, California, United States); ERK1/2 (06-182; Upstate Biotechnology); c-Src (SRC2 and sc-18; Santa Cruz Biotechnology); Phospho-Src Y418 (44-660; Biosource International, Camarillo, California, United States); Phospho-ERK1/2 (9101; Cell Signaling Technology); PLCgamma (05-163; Upstate Biotechnology); SHP-2 (sc-280; Santa Cruz Biotechnology); and phosphotyrosine (4G10) (05-321; Upstate Biotechnology). PDGFRbeta 97A (kinase insert domain) was a kind gift from Andrius Kazlauskas.
###end p 55
###begin title 56
Supporting Information
###end title 56
###begin title 57
Accession Numbers
###end title 57
###begin p 58
The LocusLink ID numbers discussed in this paper are PDGFRalpha (Locus ID 18595) and PDGFRbeta (Locus ID 18596).
###end p 58
###begin p 59
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XlacZ4</italic>
###xml 614 619 <span type="species:ncbi:9606">Child</span>
###xml 631 636 <span type="species:ncbi:9606">Human</span>
We thank Moshe Shani for the XlacZ4 transgenic line; Andrius Kazlauskas for antibodies; Elizabeth Behler, Philip Corrin, Triston Dougall, Jason Frazier, and Tara Swamy for excellent technical support; and our laboratory colleagues for discussions and critical comments on the manuscript. MDT was supported in part by a fellowship from the American Cancer Society (PF-98-149-01). This work was supported in part by research grant 0330351N from the American Heart Association and grant 5-FY03-14 from the March of Dime Birth Defects Foundation to MDT and by grants HD24875 and HD25326 from the National Institute of Child Health and Human Development to PS.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
Analysis of mural cell recruitment to tumor vessels
###end article-title 61
###begin article-title 62
Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation
###end article-title 62
###begin article-title 63
A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
###end article-title 63
###begin article-title 64
Developmental roles of platelet-derived growth factors
###end article-title 64
###begin article-title 65
Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3'-kinase is essential for male fertility
###end article-title 65
###begin article-title 66
Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae
###end article-title 66
###begin article-title 67
Signal transduction by the PDGF receptors
###end article-title 67
###begin article-title 68
Chimaeric analysis reveals role of PDGF receptors in all muscle lineages
###end article-title 68
###begin article-title 69
Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding
###end article-title 69
###begin article-title 70
Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy
###end article-title 70
###begin article-title 71
Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor
###end article-title 71
###begin article-title 72
Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
###end article-title 72
###begin article-title 73
Analysis of mutant platelet-derived growth factor receptors expressed in PC12 cells identifies signals governing sodium channel induction during neuronal differentiation
###end article-title 73
###begin article-title 74
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Widespread recombinase expression using FLPeR (flipper) mice
###end article-title 74
###begin article-title 75
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 60 67 <span type="species:ncbi:8355">Xenopus</span>
The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes
###end article-title 75
###begin article-title 76
Combinatorial signaling in the specification of unique cell fates
###end article-title 76
###begin article-title 77
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Akt</italic>
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
###end article-title 77
###begin article-title 78
Disruption of T cell signaling networks and development by Grb2 haploid insufficiency
###end article-title 78
###begin article-title 79
Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors
###end article-title 79
###begin article-title 80
Evolutionary divergence of platelet-derived growth factor alpha receptor signaling mechanisms
###end article-title 80
###begin article-title 81
Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis
###end article-title 81
###begin article-title 82
###xml 11 19 11 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hedgehog</italic>
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila hedgehog acts as a morphogen in cellular patterning
###end article-title 82
###begin article-title 83
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Mechanism of action and in vivo role of platelet-derived growth factor
###end article-title 83
###begin article-title 84
Signal transduction via platelet-derived growth factor receptors
###end article-title 84
###begin article-title 85
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse
###end article-title 85
###begin article-title 86
Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis
###end article-title 86
###begin article-title 87
Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling
###end article-title 87
###begin article-title 88
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
###end article-title 88
###begin article-title 89
Developmental biology of the vascular smooth muscle cell: Building a multilayered vessel wall
###end article-title 89
###begin article-title 90
Active and inactive protein kinases: Structural basis for regulation
###end article-title 90
###begin article-title 91
PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex
###end article-title 91
###begin article-title 92
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis
###end article-title 92
###begin article-title 93
Phosphorylation of the PDGF receptor beta subunit creates a tight binding site for phosphatidylinositol 3 kinase
###end article-title 93
###begin article-title 94
Binding of GAP to activated PDGF receptors
###end article-title 94
###begin article-title 95
The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp
###end article-title 95
###begin article-title 96
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kit</italic>
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kit</italic>
###xml 146 149 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kit</italic>
Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses
###end article-title 96
###begin article-title 97
Identification of a putative Syp substrate, the PDGF beta receptor
###end article-title 97
###begin article-title 98
The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions
###end article-title 98
###begin article-title 99
An allelic series at the PDGFalphaR locus indicates unequal contributions of distinct signaling pathways during development
###end article-title 99
###begin article-title 100
Regulation of chemotaxis by the platelet-derived growth factor receptor-beta
###end article-title 100
###begin article-title 101
Association between the PDGF receptor and members of the Src family of tyrosine kinases
###end article-title 101
###begin article-title 102
###xml 119 124 <span type="species:ncbi:9606">human</span>
Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor
###end article-title 102
###begin article-title 103
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities
###end article-title 103
###begin article-title 104
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
###end article-title 104
###begin article-title 105
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development
###end article-title 105
###begin article-title 106
Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli
###end article-title 106
###begin article-title 107
Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP): Evidence for integrated co-receptor function between LRP and the PDGF
###end article-title 107
###begin article-title 108
Coupling Met to specific pathways results in distinct developmental outcomes
###end article-title 108
###begin article-title 109
Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro
###end article-title 109
###begin article-title 110
Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors
###end article-title 110
###begin article-title 111
Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor: Involvement in the interaction with Src family tyrosine kinases
###end article-title 111
###begin article-title 112
Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-gamma with the PDGF receptor signaling complex
###end article-title 112
###begin article-title 113
Direct and long-range action of a DPP morphogen gradient
###end article-title 113
###begin article-title 114
Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor
###end article-title 114
###begin article-title 115
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos
###end article-title 115
###begin article-title 116
DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases
###end article-title 116
###begin article-title 117
Regulation and role of PDGF receptor alpha-subunit expression during embryogenesis
###end article-title 117
###begin article-title 118
alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF
###end article-title 118
###begin article-title 119
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Expression of platelet-derived growth factor and its receptors in the developing and adult mouse kidney
###end article-title 119
###begin article-title 120
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice
###end article-title 120
###begin article-title 121
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
PDGFRalpha expression during mouse embryogenesis: Immunolocalization analyzed by whole-mount immunohistostaining using the monoclonal anti-mouse PDGFRalpha antibody APA5
###end article-title 121
###begin article-title 122
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Epiblast-restricted Cre expression in MORE mice: A tool to distinguish embryonic vs. extra-embryonic gene function
###end article-title 122
###begin article-title 123
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Retention of PDGFR-beta function in mice in the absence of phosphatidylinositol 3'-kinase and phospholipase Cgamma signaling pathways
###end article-title 123
###begin article-title 124
A novel transgenic marker for migrating limb muscle precursors and for vascular smooth muscle cells
###end article-title 124
###begin article-title 125
Src family tyrosine kinases and the response to platelet-derived growth factor
###end article-title 125
###begin article-title 126
Mitogen-activated protein kinase activation is insufficient for growth factor receptor-mediated PC12 cell differentiation
###end article-title 126
###begin article-title 127
Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal
###end article-title 127
###begin article-title 128
Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins
###end article-title 128
###begin article-title 129
Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling
###end article-title 129
###begin article-title 130
Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase
###end article-title 130
###begin article-title 131
The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration
###end article-title 131
###begin article-title 132
###xml 114 124 <span type="species:ncbi:7227">Drosophila</span>
Overlapping activators and repressors delimit transcriptional response to receptor tyrosine kinase signals in the Drosophila eye
###end article-title 132
###begin article-title 133
Direct interaction between Shc and the platelet-derived growth factor beta-receptor
###end article-title 133
###begin article-title 134
Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors
###end article-title 134
###begin article-title 135
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wingless</italic>
Direct and long-range action of a wingless morphogen gradient
###end article-title 135
###begin article-title 136
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 77 82 <span type="species:ncbi:9606">human</span>
Specific expression in mouse mesoderm- and neural crest-derived tissues of a human PDGFRA promoter/lacZ transgene
###end article-title 136
###begin title 137
Abbreviations
###end title 137
###begin p 138
extracellular signal-related kinase
###end p 138
###begin p 139
embryonic stem
###end p 139
###begin p 140
green fluorescent protein
###end p 140
###begin p 141
mitogen-activated protein kinase
###end p 141
###begin p 142
###xml 0 5 <span type="species:ncbi:10090">mouse</span>
mouse embryonic fibroblast
###end p 142
###begin p 143
platelet-derived growth factor
###end p 143
###begin p 144
platelet-derived growth factor receptor
###end p 144
###begin p 145
phosphatidylinositol 3'-kinase
###end p 145
###begin p 146
phospholipase Cgamma
###end p 146
###begin p 147
receptor tyrosine kinase
###end p 147
###begin p 148
Src family kinase
###end p 148
###begin p 149
Src homology domain 2
###end p 149
###begin p 150
SH2-containing phosphotyrosine phosphatase
###end p 150
###begin p 151
smooth muscle actin alpha
###end p 151
###begin p 152
signal transducer and activator of transcription
###end p 152
###begin p 153
vascular smooth muscle cell/pericyte
###end p 153
###begin p 154
vascular smooth muscle cell
###end p 154
###begin title 155
Figures and Tables
###end title 155
###begin title 156
PDGFRbeta Allelic Series
###end title 156
###begin p 157
###xml 316 332 313 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000052-Mori1">Mori et al. 1993</xref>
###xml 362 363 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
This figure depicts the mutant alleles generated in the mouse PDGFRbeta genomic locus. X represents a mutation in the tyrosine-binding site(s) for a particular signal transduction molecule. The F7 allele contains a disruption in one SFK-binding site because loss of both sites results in diminished kinase activity (Mori et al. 1993). The truncation allele (betaT) was created by deletion and subsequent frameshift that results in a stop codon 32 amino acids past the RasGAP-binding site.
###end p 157
###begin title 158
Targeting Strategy and Southern Blot
###end title 158
###begin p 159
(A) Targeting vector used to create F5 mutant allele. Two exons contain all five mutated tyrosines.
###end p 159
###begin p 160
(B) Targeting vector containing mutations in 5' exons used to generate the F7 mutant allele.
###end p 160
###begin p 161
(C) Wild-type allele.
###end p 161
###begin p 162
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spe</italic>
###xml 89 92 89 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Asp</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sac</italic>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 146 149 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
(D) Targeted allele with PGK-neo removal. Restriction enzyme abbreviations: Sp, SpeI; A, Asp718; S, SacI; RV, EcoRV; H, HindIII; X, XhoI; and RI, EcoRI. Green boxes indicate probes used in Southern blotting for F7-targeted ES cells. The blue arrow indicates the exon where point mutation causes frameshift in truncation mutation. Black boxes indicate wild-type exons. Red boxes indicate exons containing targeted mutations. Restriction enzymes in red indicate sites introduced by mutagenesis to verify proper homologous recombination by Southern blotting. Circles denote FRT sites. Triangles denote loxP sites.
###end p 162
###begin p 163
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spe</italic>
(E) Southern blot results from various ES cell lines. SpeI digest using P1 probe. Blot with P2 probe gave expected results (data not shown). Lanes 1 and 3, F5 allele targeted. Lanes 2 and 4, wild-type allele targeted. Lanes 5 and 7, F5 mutant ES cells after and before Cre activity, respectively. Lane 6, wild-type ES cell clone.
###end p 163
###begin title 164
###xml 20 24 <span type="species:ncbi:10090">Mice</span>
Eye Defects in F5/- Mice
###end title 164
###begin p 165
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
(A) Eyes from a P4 F5/- mouse demonstrating severe hemorrhaging. (B and C) H/E-stained sagittal sections through eyes of wild-type and F5/- 3-mo-old mice, respectively. The absence of the lens of the F5/- eye is a histological defect and not a phenotype of the F5/- eye. L, lens; R, retina.
###end p 165
###begin title 166
V/P Populations in P28 Retinas
###end title 166
###begin p 167
Whole-mount retinal preparations from wild-type and mutant eyes. Pigmented epithelium was removed for visualization of beta-galactosidase. Note F7/F7 and F7/- had extensive thickening of the retinal layers that resulted in a contraction of the entire retina and apparent reduction in size. The far right panel shows a close-up of the artery and vein of three homozygous eyes.
###end p 167
###begin title 168
Vascular Smooth Muscle Cells of the Coronary Arteries
###end title 168
###begin p 169
###xml 83 87 <span type="species:ncbi:10090">mice</span>
(Top) Whole-mount views of P21 hearts from littermates of the F5 alleles of mutant mice. Hearts were sliced coronally, and the ventral surface was photographed. The F5/- heart was sliced disproportionately and therefore appears to be smaller.
###end p 169
###begin p 170
(Bottom) P28 hearts from wild-type and F1 littermates. Hearts were sliced sagittally. Both the left and right views are shown.
###end p 170
###begin title 171
Tissue Localization of V/P Cell Markers and PDGFRalpha Expression
###end title 171
###begin p 172
###xml 39 44 35 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP/+</sup>
###xml 54 59 47 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F5/F5</sup>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Tissue preparations from P21 PDGFRalphaGFP/+;PDGFRbetaF5/F5 mutant mouse. Immunofluorescence was used to detect alphaSMA (A and B), desmin (C), beta-galactosidase (D), and GFP expression for PDGFRalpha (A-D). (A) Kidney (200 mum vibratome section). The arrow indicates glomerulus. The asterisk indicates an arteriole. (B-D) Retina (whole-mount preparation). Arrowheads point to beta-galactosidase-positive nuclei.
###end p 172
###begin title 173
Reduction in V/P Cells in the Thoracic Region of E14.5 Embryos
###end title 173
###begin p 174
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XlacZ4</italic>
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Ventral view of E14.5 wild-type and F7/- littermates with the XlacZ4 mouse marker background. beta-Galactosidase-positive nuclei represent v/p cells. Th, thymus.
###end p 174
###begin title 175
Pericytes within the E14.5 Nervous System of F Series Mutant Embryos
###end title 175
###begin p 176
(A) Representative sections through neural tubes of embryos from the homozygous F allelic series. (B) Representative sections of embryos from the hemizygous allelic series (F series mutant with one copy of the null allele). Sections are from the rostral level between the heart and kidney. Pericytes are visualized by nuclear-localized beta-galactosidase staining in cells committed to the v/p lineage. Sections are 7 mum.
###end p 176
###begin title 177
Quantitation of Pericytes in Nervous System
###end title 177
###begin p 178
###xml 440 441 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 627 628 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 721 724 715 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 726 727 720 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
beta-Galactosidase-positive nuclei were counted within the neural tube. Each datapoint represents a mean of seven to ten sections from a single embryo. Data were gathered at two rostral levels in each embryo. The genotypes are ordered by the predicted strength of the signal, depending on the number of copies of the receptor being expressed and the signal transduction pathways remaining downstream of the receptor. A two-tailed Student's t-test was performed comparing the number of spinal cord perictyes in mutants to those in wild-type, and all homozygous mutants and hemizygous mutant values were statistically different (p < 0.005) from wild-type values. The F1/- was also statistically different from the PDGFRbeta+/- (p < 0.001).
###end p 178
###begin title 179
###xml 36 40 <span type="species:ncbi:10090">Mice</span>
Biochemistry of MEFs from F7 and F1 Mice
###end title 179
###begin p 180
(A) Whole-cell lysates were generated from MEFs that were unstimulated or stimulated with PDGFAA and/or PDGFBB alone, 100 ng/ml and 30 ng/ml, respectively. Lysates were then subjected to SDS-PAGE and Western blotting accomplished with the anti-phosphotyrosine antibody (4G10).
###end p 180
###begin p 181
###xml 204 207 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">418</sup>
(B) Immunoprecipitation of tyrosine-phosphorylated proteins from wild-type and the F7 series of mutant MEFs. The precipitates were then run on SDS-PAGE, and a Western blot was performed using anti-Src [pY418] antibody and anti-PDGFRbeta 97A.
###end p 181
###begin p 182
(C) Whole-cell lysates from unstimulated or stimulated MEFs. Lysates were then subjected to SDS-PAGE and Western blotting accomplished with the indicated phosphorylated-specific antibodies. Blots were stripped and blotted with antibodies to the corresponding unphosphorylated proteins to demonstrate protein loading. Data are representative of multiple experiments from at least two independently derived cell lines.
###end p 182
###begin p 183
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
(D) Western blots of whole-cell lysates from 5 x104 cells per lane blotted with antibodies to PDGFRbeta (06-498) and ERK as a loading control.
###end p 183
###begin p 184
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflicts of Interest.</bold>
Conflicts of Interest. The authors have declared that no conflicts of interest exist.
###end p 184
###begin p 185
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author Contributions.</bold>
Author Contributions. MDT and PS conceived and designed the experiments. MDT and WJF performed the experiments. MDT analyzed the data. MDT wrote the paper.
###end p 185
###begin p 186
Academic Editor: Roel Nusse, Stanford University School of Medicine
###end p 186

